APTOSE BIOSCIENCES INC's ticker is and the CUSIP is 03835T200. A total of 53 filers reported holding APTOSE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,736 | +15.0% | 37,087 | +4.2% | 0.00% | – |
| Q4 2022 | $20,640 | +194.9% | 35,587 | +184.7% | 0.00% | – |
| Q3 2022 | $7,000 | -22.2% | 12,500 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | -47.1% | 12,500 | 0.0% | 0.00% | – |
| Q1 2022 | $17,000 | -22.7% | 12,500 | -22.6% | 0.00% | – |
| Q4 2021 | $22,000 | -50.0% | 16,150 | -19.9% | 0.00% | – |
| Q3 2021 | $44,000 | -52.2% | 20,150 | -27.1% | 0.00% | – |
| Q2 2021 | $92,000 | -44.2% | 27,650 | 0.0% | 0.00% | – |
| Q1 2021 | $165,000 | +25.0% | 27,650 | -8.0% | 0.00% | – |
| Q4 2020 | $132,000 | -26.7% | 30,050 | 0.0% | 0.00% | – |
| Q3 2020 | $180,000 | +9.8% | 30,050 | +15.4% | 0.00% | – |
| Q2 2020 | $164,000 | -3.0% | 26,050 | -8.3% | 0.00% | – |
| Q1 2020 | $169,000 | +24.3% | 28,400 | +18.3% | 0.00% | – |
| Q4 2019 | $136,000 | – | 24,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 2,900,000 | $12,702,000 | 3.02% |
| P.A.W. CAPITAL CORP | 750,000 | $3,285,000 | 2.90% |
| Prosight Management, LP | 824,795 | $3,613,000 | 1.67% |
| Voss Capital, LLC | 715,000 | $3,132,000 | 1.58% |
| DRW Securities, LLC | 7,976,176 | $34,936,000 | 1.23% |
| Ally Bridge Group (NY) LLC | 1,409,150 | $6,172,000 | 1.06% |
| Nantahala Capital Management | 7,272,673 | $31,854,000 | 0.99% |
| SANDERS MORRIS HARRIS LLC | 925,153 | $4,231,000 | 0.96% |
| PRECEPT MANAGEMENT LLC | 440,696 | $1,930,000 | 0.78% |
| Endurant Capital Management LP | 477,895 | $2,093,000 | 0.76% |